These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2147450)

  • 21. Midwives and anti-D. Enabling choice.
    Wickham S
    Pract Midwife; 2000 Nov; 3(10):11-2. PubMed ID: 12026485
    [No Abstract]   [Full Text] [Related]  

  • 22. IRB-identified ethical issues in nursing research.
    Olsen DP; Mahrenholz D
    J Prof Nurs; 2000; 16(3):140-8. PubMed ID: 10860312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic determinism and the overprotection of human subjects.
    Wilcox AJ; Taylor JA; Sharp RR; London SJ
    Nat Genet; 1999 Apr; 21(4):362. PubMed ID: 10192384
    [No Abstract]   [Full Text] [Related]  

  • 24. Making Ohio's do-not-resuscitate law work. A self-study program for health care providers (RNs, LPNs, case managers).
    Lycan J
    Ohio Nurses Rev; 2000 Sep; 75(8):9-13; quiz 13. PubMed ID: 15706834
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk management.
    Graskemper J
    Dent Today; 2000 Dec; 19(12):32, 36-7. PubMed ID: 12524832
    [No Abstract]   [Full Text] [Related]  

  • 26. [Status quo and problems in phase III trials: view of a trialist].
    Hamajima N
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):319-22. PubMed ID: 7880101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter by Augoustides regarding article "Aprotinin does not increase the risk of renal failure in cardiac surgery patients".
    Augoustides JG
    Circulation; 2008 Jun; 117(22):e474; author reply e476. PubMed ID: 18519856
    [No Abstract]   [Full Text] [Related]  

  • 28. Meta-analysis of randomized clinical trials in cancer.
    Buyse M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
    [No Abstract]   [Full Text] [Related]  

  • 29. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Kim SY; Kim HM; McCallum C; Tariot PN
    Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines.
    Neugebauer B; Drai C; Haase M; Hilger A; Keller-Stanislawski B; Laitinen-Parkkonen P; Mentzer D; Rasmussen C; Ratignier C; Seitz R
    Haemophilia; 2008 Jan; 14(1):142-4. PubMed ID: 18070062
    [No Abstract]   [Full Text] [Related]  

  • 33. Meta-analysis of controlled clinical trials.
    Naylor CD
    J Rheumatol; 1989 Apr; 16(4):424-6. PubMed ID: 2746582
    [No Abstract]   [Full Text] [Related]  

  • 34. Placebo usage in clinical trials of life-saving drugs.
    Prog Clin Biol Res; 1980; 38():257-60. PubMed ID: 7384131
    [No Abstract]   [Full Text] [Related]  

  • 35. Waiving informed consent for research on spiritual matters?
    Goldstein J
    Arch Intern Med; 2000 Jun; 160(12):1870-1; author reply 1877-8. PubMed ID: 10871986
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical disagreement.
    Meyers D
    Med J Aust; 1991 Aug; 155(4):278. PubMed ID: 1750919
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical protocols: how are they constructed? Proposal of a model for its design and elaboration. Evaluation and Improvement of Clinical Protocols Group].
    Saura Llamas J; Saturno Hernández P
    Aten Primaria; 1996 Jun; 18(2):91-6. PubMed ID: 8924571
    [No Abstract]   [Full Text] [Related]  

  • 38. Exposure response--getting the dose right.
    Pinheiro J; Duffull S
    Pharm Stat; 2009; 8(3):173-5. PubMed ID: 19753557
    [No Abstract]   [Full Text] [Related]  

  • 39. [The development and enforcement of clinical protocols and its evaluation of the results of statistical analysis (1990 revision)].
    Gan No Rinsho; 1990 Nov; 36(14):2503-25. PubMed ID: 2147450
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintaining informed consent validity during lengthy research protocols.
    Prentice KJ; Appelbaum PS; Conley RR; Carpenter WT
    IRB; 2007; 29(6):1-6. PubMed ID: 18237078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.